Tag | Content |
---|
EnhancerAtlas ID | HS098-52861 |
Organism | Homo sapiens |
Tissue/cell | HSMM |
Coordinate | chr7:101929240-101931370 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
KLF16 | MA0741.1 | chr7:101930020-101930031 | GGGGGCGGGGC | - | 6.02 | KLF16 | MA0741.1 | chr7:101930056-101930067 | GGGGGCGGGGC | - | 6.02 | KLF16 | MA0741.1 | chr7:101930081-101930092 | GGGGGCGGGGC | - | 6.02 | KLF16 | MA0741.1 | chr7:101930111-101930122 | GGGGGCGGGGC | - | 6.02 | KLF16 | MA0741.1 | chr7:101929568-101929579 | GGGGGCGTGGT | - | 6.14 | KLF5 | MA0599.1 | chr7:101930021-101930031 | GGGGCGGGGC | - | 6.02 | KLF5 | MA0599.1 | chr7:101930057-101930067 | GGGGCGGGGC | - | 6.02 | KLF5 | MA0599.1 | chr7:101930082-101930092 | GGGGCGGGGC | - | 6.02 | KLF5 | MA0599.1 | chr7:101930112-101930122 | GGGGCGGGGC | - | 6.02 | NHLH1 | MA0048.2 | chr7:101929959-101929969 | CGCAGCTGCG | + | 6.02 | NHLH1 | MA0048.2 | chr7:101930365-101930375 | CGCAGCTGCG | + | 6.02 | NHLH1 | MA0048.2 | chr7:101929959-101929969 | CGCAGCTGCG | - | 6.02 | NHLH1 | MA0048.2 | chr7:101930365-101930375 | CGCAGCTGCG | - | 6.02 | SP1 | MA0079.4 | chr7:101930019-101930034 | CGGGGGCGGGGCCTG | - | 6.11 | SP1 | MA0079.4 | chr7:101930055-101930070 | AGGGGGCGGGGCCAG | - | 6.57 | SP2 | MA0516.2 | chr7:101930054-101930071 | GAGGGGGCGGGGCCAGG | - | 6.09 | SP3 | MA0746.2 | chr7:101930080-101930093 | GGGGGGCGGGGCC | - | 6.11 | SP3 | MA0746.2 | chr7:101929567-101929580 | AGGGGGCGTGGTG | - | 6.29 | SP4 | MA0685.1 | chr7:101930053-101930070 | GGAGGGGGCGGGGCCAG | - | 7.25 | SP8 | MA0747.1 | chr7:101929567-101929579 | AGGGGGCGTGGT | - | 6.52 | Zfx | MA0146.2 | chr7:101930020-101930034 | GGGGGCGGGGCCTG | + | 6.19 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_58693 | chr7:101922324-101974102 | Ly1 | SE_60412 | chr7:101921972-101976670 | DHL6 | SE_61924 | chr7:101916815-101972690 | Toledo |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr7 | 101929978 | 101930313 | chr7 | 101929501 | 101929660 |
|
Enhancer Sequence | TGCACCTCTT TCAGGAAGCC TCCCAGAGCC CCCGCGCCGT GCCCTCAGCA CCAGGGGTCA 60 GGCTACAAAT GCCCCGCAAA GCCCAGCGGG ACTGTTTCCT CAGCCCCACT GGTCTCTGCC 120 CTAAAGCAGG CGAGTTCTGG AGCCAGGCAG GGGTGAGGAA GGTGCCAGGG TTGTGGCCCC 180 TCATCGCCCC TCTATGATCT CTGACACCTC TCCGGGTGGC ATCAGGCCCC CATCACAGCG 240 AAGGCTGGGT GGTGGGGGCA CTGCGCTCAG GGGGGCCGTC CCGCCCTGTG GCCCGGGGGC 300 GATTTCCCGC ACCGGAGGGC TGCAGGGAGG GGGCGTGGTG GCGCCCTCGA GATTTATGAG 360 AACCAGGCGT CGACTTCCTC CGTTGCGACA TCCAGGCCTC CTCCAGGCTC CCATTGTCCC 420 TGCTGCGGAG AGTCTGGCCA CAGCGGCGGC TCCCGCGAAG CACCCGTCAG CGAGGGGCGC 480 TTCGAGGGCG TCCGCGTCCC ATACACCCGC CACGCAGGAC ATTCCCCCGG CCCCACGCTC 540 CGCGCTCCCG GGGCCACCAC CACCGCGGGC TCGAGGGGTG GCCTCCACGA GGAGGAGTGG 600 GAGTCCCGCG CCTGGCCTGG GGCCGGCTCG GCGACATGGG GACCCCCGCC CAGATGGGGC 660 GACTCGGAGC CGGCTCCTAA CCCCTCTCTC CGGGCCCCAG GACCGGGCAG TCTCGGCACC 720 GCAGCTGCGG GGAGCCAGCA AGCACCGGCC ACCGGCGCCG CTCGGGCTCC GCGGATGGCC 780 GGGGGCGGGG CCTGAGCGGC GCAAGTGGGG GCGGGAGGGG GCGGGGCCAG GACGCGCGAG 840 GGGGGGCGGG GCCGGGGCTC GCGGCGGGGG CGGGGGCGGG GCCGGGGCCG GGAGGCGCGC 900 GCCTCGCGGG CGGGGGGCGC GCCGCGCTGG GCTGGGCTTG GAGCGCGCGG AGCTCGGCTG 960 CCAGAGAGCC GCGCGGGGGA CGCGCCGGGA CCGCGAGGAG CGCAGGAGCC TTCGAGGCGG 1020 TGAACGAGGG AGGGAGCCCA GTCCGCCGCG GGCCATGAGC CACCGGGCCC GGGGAGCCCG 1080 GCCGCGGTCC GGGCAGCGCT CAGCCGGCGC CCCAGCCCGC TCGGCCGCAG CTGCGCGCCT 1140 GTAGGTATGG CCTCCTTATA CCCAGTTCCT CGCTCCCTGG TCCTTCCCCC GGGACCCCTG 1200 TCTGTCCCCG GGGACGTGCG CTGTGTGCGC ACCGCTGCCC GAAGGAGAGC GGCCGCACGC 1260 GCCTTGGTCC GCGCGTGTCG TCTTTGTGTG CGCGGGTGGG AGGGAGGAGG GCGCGCGAGG 1320 GAGGGGAGGC GCCCCCGGCT GGGATCTGCT CCCCGATCCC CATCCCGGGC GGGGCGGGGA 1380 GCCGCTGGAG GGGCCGAGCC GCCTCTGGAG CAGCTGCGCC CCCGCCCCCT GCTAGGGCCC 1440 CGGCCGGGTA GTGGGGCGAG AGCAGCCGGG TCCTTAGAGG AGGGGTCTCT GGTTGGGGGA 1500 AGGGGTGCCC AGGTCTCTTC CCTACGCTGG GAGCGCTGGG AGGGGGCGTC AACCTAGAAT 1560 GAGGGTGAGG GCCACGGGAT GGGATCGGGG AGGACCTCCT CCAGGCCACA GGCACGCCCT 1620 CCCTTTGGCC CAGGCCCCCC TTTCTCGACC TGCCCAGCCG GGGAGCTCCC CGGAGCCCCC 1680 GATTGCCGGG AGGATCGTGG AGGGTGCCCA AGAGGCCGGC GCCTTTAAGA AGGGGCGGGT 1740 TCGTGCCCTC CATTCAGGCC CTTGGGCCTC GGCCATTGAT GAACCTGCGG GCTGCGCGGG 1800 CCGGAACCGC GCCAGCCCAG CGGGCTGAAG CCGGGCAGAG GCAGGGACGC ATCCTGGCCC 1860 CCTGCAGCCC CGAAGTGGGG GCCTTCAGGG AGGGAAGTCT GCAGTGACTG GAGCCTCTCA 1920 GGAGCCACGC AAGGCAGACC GGGCAGCCCC AGGCGAGACT CTGAACACGA ATAAGCCAGG 1980 ATCTACGTGC ACTTCGAGCT AGTGCAAGGG AGAGCCTCAG GCTAGGCTGT CAGACCTGGG 2040 TGGAGCCCTA CCAATGCCCC CGAGCCAACA TCACCTACCC TGTAAAATGG GATGGTGCTG 2100 CCTGCCTCCT GGCTAAGGGA CCGGCAACTC 2130
|